Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Metadata
Title
Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome
Author
Glen E. Duncan, PhD, RCEPSM
Publication date
01-01-2006
Publisher
Current Medicine Group
Published in
Current Diabetes Reports / Issue 1/2006
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-006-0048-1

Other articles of this Issue 1/2006

Current Diabetes Reports 1/2006 Go to the issue

Clinical Trials Report

The safety and efficacy of statin therapy: An expanding database

OriginalPaper

Endothelial function and the prediction of CVD in diabetes

OriginalPaper

Metabolic syndrome in the elderly

OriginalPaper

The renin-angiotensin system and its blockade in diabetic renal and cardiovascular disease

Clinical Trials Report

The PROactive study: Pioglitazone in the secondary prevention of macrovascular events in patients with type 2 diabetes

News

Web alert

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits